Literature DB >> 30778828

Ambulatory blood pressures and central blood pressures are associated with cardiovascular morbidity in adolescent and young adult patients receiving chronic hemodialysis.

Shweta Shah1, Sarah Swartz2, Jessica Campbell2, Poyyapakkam R Srivaths2.   

Abstract

BACKGROUND: Left ventricular hypertrophy (LVH) and arterial stiffness measured by pulse wave velocity (PWV) are independent predictors of cardiovascular (CV) mortality in adults receiving chronic dialysis. Hypertension strongly associates with elevated left ventricular mass index (LVMI) and PWV, with ambulatory blood pressure monitoring (ABPM), and central blood pressure (CBP) superior to office blood pressures (BP) in predicting CV morbidity. Few studies have described associations of office BP, ABPM, and CBP with LVMI and PWV in adolescent and young adult patients receiving hemodialysis (HD).
METHODS: Cross-sectional study of 22 adolescents and young adults receiving chronic HD. Pre- and post-dialysis office BP and CBP using applanation tonometry were obtained. Twenty-four-hour ABPM was obtained midweek post-dialysis. Pre- and post-dialysis carotid-brachial PWV were obtained same day as BP measurements. Annual echocardiograms for standard care were reviewed for LVH.
RESULTS: Pre-dialysis CBP index correlated with LVMI (r = 0.3, p = 0.04) and PWV (r = 0.48, p = 0.02). Hypertensive patients identified by ABPM had worse LVMI; daytime ABPM systolic BP index correlated with LVMI (r = 0.5, p = 0.02). Office BP was not associated with LVMI; only office diastolic BP was associated with PWV (r = 0.46, p = 0.02). There was no correlation of LVMI or PWV with bone health parameters, anemia, interdialytic weight gain, or residual renal function.
CONCLUSIONS: Ambulatory blood pressure monitoring is superior to casual office BP obtained at time of dialysis in delineating cardiovascular morbidity in adolescent and young adult HD patients. CBP is easily performed and correlates with LVMI and PWV in adolescent and young adult HD patients; however, large-scale normative data is needed.

Entities:  

Keywords:  ABPM; Central blood pressure; Hemodialysis; LVH; Pediatric; Pulse wave velocity

Mesh:

Year:  2019        PMID: 30778828     DOI: 10.1007/s00467-019-04208-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  44 in total

1.  Ambulatory Pulse Wave Velocity Is a Stronger Predictor of Cardiovascular Events and All-Cause Mortality Than Office and Ambulatory Blood Pressure in Hemodialysis Patients.

Authors:  Pantelis A Sarafidis; Charalampos Loutradis; Antonios Karpetas; Georgios Tzanis; Alexia Piperidou; Georgios Koutroumpas; Vasilios Raptis; Christos Syrgkanis; Vasilios Liakopoulos; Georgios Efstratiadis; Gérard London; Carmine Zoccali
Journal:  Hypertension       Date:  2017-05-08       Impact factor: 10.190

2.  Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors.

Authors:  M M Mitsnefes; S R Daniels; S M Schwartz; R A Meyer; P Khoury; C F Strife
Journal:  Pediatr Nephrol       Date:  2000-09       Impact factor: 3.714

3.  Increased arterial stiffness in children on haemodialysis.

Authors:  Adrian Covic; Nicoleta Mardare; Paul Gusbeth-Tatomir; Ovidiu Brumaru; Cristina Gavrilovici; Mihaela Munteanu; Octavian Prisada; David J A Goldsmith
Journal:  Nephrol Dial Transplant       Date:  2005-10-12       Impact factor: 5.992

4.  Impact of aortic stiffness on survival in end-stage renal disease.

Authors:  J Blacher; A P Guerin; B Pannier; S J Marchais; M E Safar; G M London
Journal:  Circulation       Date:  1999-05-11       Impact factor: 29.690

5.  Cardiovascular disease in pediatric chronic dialysis patients.

Authors:  Blanche M Chavers; Shuling Li; Allan J Collins; Charles A Herzog
Journal:  Kidney Int       Date:  2002-08       Impact factor: 10.612

6.  Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD.

Authors:  Sophia Zoungas; James D Cameron; Peter G Kerr; Rory Wolfe; Christine Muske; John J McNeil; Barry P McGrath
Journal:  Am J Kidney Dis       Date:  2007-10       Impact factor: 8.860

7.  Cardiovascular mortality in children and young adults with end-stage kidney disease.

Authors:  R S Parekh; C E Carroll; R A Wolfe; F K Port
Journal:  J Pediatr       Date:  2002-08       Impact factor: 4.406

8.  Masked hypertension associates with left ventricular hypertrophy in children with CKD.

Authors:  Mark Mitsnefes; Joseph Flynn; Silvia Cohn; Joshua Samuels; Tom Blydt-Hansen; Jeffrey Saland; Thomas Kimball; Susan Furth; Bradley Warady
Journal:  J Am Soc Nephrol       Date:  2009-11-16       Impact factor: 10.121

9.  Impact of left ventricular hypertrophy on survival in end-stage renal disease.

Authors:  J S Silberberg; P E Barre; S S Prichard; A D Sniderman
Journal:  Kidney Int       Date:  1989-08       Impact factor: 10.612

10.  Traditional and "new" cardiovascular risk markers and factors in pediatric dialysis patients.

Authors:  Mahmut Civilibal; Salim Caliskan; Huseyin Oflaz; Lale Sever; Cengiz Candan; Nur Canpolat; Ozgur Kasapcopur; Zehra Bugra; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2007-03-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.